ESG News For ASOS PLC

Research, supported by the Wolverine Foundation and published in JCI Insights, characterizes a mutation in MAPK8IP3 that disrupts dopamine signaling

Annual 5k and music festival prepares to celebrate two decades of raising millions of dollars for South Florida HIV/AIDS nonprofit, service organizations

Case study, published in Nature Medicine, details improvements in nano-rare patient, Susannah’s seizure severity, neurologic function and quality of life

Simplify Healthcare partners with its not-for-profit affiliate, Maker’s Merci, to donate $15,000 to local shelters, organizations helping seniors, veterans, autism, foster kids, burn victims, disaster relief, and children’s hospital. The funds provided holiday meals, food drives/meal support, toy drives, Amazon wish list items, and wishes walls (foster kids’ holiday wishes).Amongst the recipients were Feeding America and Loaves & Fishes.Feeding America is a leading hunger relief organization wit

Patagonia has been on the right path for decades, but representing only 0.09% of the fashion industry, Patagonia alone can’t save the world

n-Lorem received a $3 million donation to support its efforts in ASO research and discovery

Parexel to provide clinical operations, real-world data solutions and expertise including medical and regulatory alongside innovative clinical research tools that will significantly enhance and streamline n-Lorem’s therapeutic development efforts

More than 200 global organizations have now joined The Climate Pledge and are pursuing ambitious carbon-reduction activities, including operational changes in the race to fight climate changeTogether, Pledge signatories generate over $1.8 trillion in global annual revenues and are expected to collectively mitigate 1.98 billion metric tons of carbon emissions annually by 2040 from a 2020 baseline

World’s largest oligonucleotide manufacturer provides drug ingredients and financial donation to support development of experimental antisense medicines, helping n-Lorem reach more patients n-Lorem’s third partnership in the last quarter boosts resources to assist patients with ultra-rare mutations